1) Versteege I, Sevenet N, Lange J, et al:Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203-206,1998
2) Judkins AR:Immunohistochemistry of INI1 expression:a new tool for old challenges in CNS and soft tissue pathology. Adv Anat Pathol 14:335-339,2007.
3) Biegel JA, Tan L, Zhang F, et al:Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8:3461-3467,2002
4) Rorke LB, Packer RJ, Biegel JA:Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood:definition of an entity. J Neurosurg 85:56-65,1996
5) Louis DN, Ohgaki H, Wiestler OD, et al:WHO Classification of Tumors of the Central Nervous System. World Health Organization Classification of Tumors 4th ed. IARC, Lyon,pp131-150,2007
6) Haberler C, Laggner U, Slavc I, et al:Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors:Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Am J Surg Pathol 30:1462-1468,2006
7) Perry A, Fuller CE, Judkins AR, et al:INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Mod Pathol 18:951-958,2005
8) Hoot AC, Russo P, Judkins AR, et al:Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol 28:1485-1491,2004
9) Modena P, Lualdi E, Facchinetti F, et al:SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res 65:4012-4019,2005